Viewing nowRisendrin Tablet 150 mg (Risedronate Sodium 2.5 Hydrate)
Risedronate Sodium 2.5 Hydrate 172.1mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

MFDS item code 201001725 · Approved 2010.02.26 · Insurance code 652903120
Treatment and prevention of osteoporosis in postmenopausal women
This medicine is used to treat and prevent osteoporosis that can occur in postmenopausal women. Osteoporosis is a condition where bones become weak, increasing the risk of fractures. This medication helps strengthen bones to prevent fractures.
Adults: Administer 150 mg of risedronate sodium orally once a month. Older adults (over 60 years): No dose adjustment is necessary because the bioavailability and pharmacodynamics of this medicine in older adults are similar to those in younger people. No dose adjustment is necessary in patients with creatinine clearance of 30 mL/min or greater. This medicine is contraindicated in patients with severe renal impairment and creatinine clearance below 30 mL/min. Food interferes with the absorption of this medicine. For adequate absorption, take it at least 30 minutes before the first food or beverage other than water of the day. To help this medicine reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ∼ 230 mL). Taking it with other beverages, including mineral water, may reduce absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. If a patient forgets to take a dose on the scheduled dosing day, follow these instructions. If the next scheduled dosing day is 7 days or more away, take 1 tablet the next morning after remembering. Take the next dose again on the originally scheduled dosing day. Do not take more than 1 tablet of this medicine within 7 days. If the next scheduled dosing day is within 7 days, wait until the originally scheduled dosing day and then take 1 tablet of this medicine.
Children under 18 years: Safety and efficacy have not been established.
This medication is an oral bisphosphonate and may irritate the gastric and esophageal mucosa, so patients with upper gastrointestinal disorders such as gastritis, esophagitis, or esophageal ulcers should use caution when taking it. In particular, if you have esophageal disorders or swallowing difficulties, you must consult a doctor before taking this medication. It should be taken with a sufficient amount of water and you should not lie down for at least 30 minutes after taking it to reduce the risk of esophageal irritation. Additionally, this medication should not be administered to patients with certain esophageal abnormalities, hypocalcemia, women who are pregnant or nursing, or patients with severe renal impairment. This medication contains lactose and dye No. 5, so those with lactose intolerance or allergies to these ingredients should use it cautiously. If you experience symptoms of esophageal irritation such as difficulty swallowing, chest pain, or heartburn while taking this medication, you should stop taking it immediately and consult a doctor. This medication is most effective when taken with calcium and vitamin D, and it should be spaced apart from medications or foods containing calcium, magnesium, iron, etc., as they may hinder absorption. Rare side effects such as jaw osteonecrosis, atypical fractures of the femur, and severe musculoskeletal pain may occur with long-term use, so report any unusual symptoms to healthcare professionals. Pregnant or nursing women should avoid taking this medication or consult a doctor before making a decision, as safety and efficacy in children under 18 years old have not been established. In case of overdose, hypocalcemia may occur, and immediate treatment should be sought if symptoms arise. It is important to keep this medication out of reach of children.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air and moisture from entering, and the recommended storage temperature is room temperature between 1 degree and 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication.
Bright blue oval film-coated tablet
1 tablet/PTP
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRisedronate Sodium 2.5 Hydrate 172.1mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Austin Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Nexpam Korea Co., Ltd.

Risedronate Sodium 2.5 Hydrate 35mg
Tablet · Prescription medication
Hyutecs Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.2mg
Tablet · Prescription medication
Celix Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Myeongmun Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Korea United Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.